Overview

A Study of Guselkumab in Participants With Active Lupus Nephritis

Status:
Recruiting
Trial end date:
2025-05-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of guselkumab in participants with active lupus nephritis (LN).
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC
Treatments:
Antibodies, Monoclonal